Biocleavable polyrotaxane-plasmid DNA polyplex for enhanced gene delivery

Journal of the American Chemical Society

Volumn 128, Issue 12, 2006, Pages 3852-3853

  Ooya, Tooru ^a   Choi, Hak Soo ^a   Yamashita, Atsushi ^a   Yui, Nobuhiko ^a   Sugaya, Yuko ^b   Kano, Arihiro ^b   Maruyama, Atsushi ^b   Akita, Hidetaka ^c   Ito, Rie ^c   Kogure, Kentaro ^c   Harashima, Hideyoshi ^c  

^a JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; DISULFIDE; DITHIOTHREITOL; PLASMID DNA; POLYCATION; POLYMER; POLYROTAXANE; UNCLASSIFIED DRUG;

ARTICLE; CONFOCAL LASER MICROSCOPY; DISSOCIATION; DISULFIDE BOND; ENDOSOME; NONVIRAL GENE DELIVERY SYSTEM; PKA; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REDUCTION; SYNTHESIS;

ALPHA-CYCLODEXTRINS; CELL NUCLEUS; DNA; ENDOSOMES; MODELS, MOLECULAR; PLASMIDS; POLYETHYLENE GLYCOLS; ROTAXANES; TRANSFECTION;

EID: 33645460372     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja055868+     Document Type: Article

References (21)

1. (a) Wolff, J. A. Nat. Biotechnol. 2002, 20, 768-769.
2. (b) Han, S.-O.; Mahato, R. I.; Sung, Y. K.; Kim, S. W. Mol. Ther. 2000, 2, 302-317.
3. (c) Nori, A.; Kopeĉek, J. Adv. Drug Delivery Rev. 2005, 57, 609-639.
4. (d) Kunath, K.; Harpe, A.; Fischer, D.; Petersen, H.; Bickel, U.; Voigt, K.; Kissel, T. J. Controlled Release 2003, 89, 113-125.
5. (e) Fukushima, S.; Miyata, K.; Nishiyama, N.; Kanayama, N.; Yamasaki, Y.; Kataoka, K. J. Am. Chem. Soc. 2005, 127, 2810-2811.
6. (f) Kong, H. J.; Liu, J.; Riddle, K.; Matsumoto, T.; Leach, K.; Mooney, D. J. Nat. Mater. 2005, 4, 460-464.
7. (a) Saito, G.; Swanson, J.; Lee, K.-D. Adv. Drug Delivery Rev. 2003, 55, 199-215.
8. (b) Read, M. L.; Bremner, K.; Oupicky, H.; Green, N. K.; Searle, P. F.; Seymour, L. W. J. Gene Med. 2003, 5, 232-245.
9. (c) Gosselin, M. A.; Guo, W.; Lee, R. J. Bioconjugate Chem. 2001, 12, 989-994.
10. (d) Miyata, K.; Kakizawa, Y.; Nishiyama, N.; Harada, A.; Yamasaki, Y.; Koyama, H.; Kataoka, K. J. Am. Chem. Soc. 2004, 126, 2355-2361.
11. Oupicky, D.; Carlisle, R. C.; Seymour, L. W. Gene Ther. 2001, 8, 713-724.
12. (a) Harada, A.; Li, J.; Kamachi, M. Nature 1992, 356, 325-328.
13. (b) Shigekawa, H.; Miyake, K.; Sumaoka, J.; Harada, A.; Komiyama, M. J. Am. Chem. Soc. 2000, 122, 5411-5412.
14. (c) Ooya, T.; Yui, N. Crit. Rev. Ther. Drug Carrier Syst. 1999, 16, 289-330.
15. (d) Ooya, T.; Eguchi, M.; Yui, N. Biomacromolecules 2001, 2, 200-203.
16. The number of α-CDs of 23 corresponds to 51% threading onto the PEG chain. Stoichiometric number of α-CDs is ca. 45, assuming that two ethylene glycol units are included in one α-CD molecule.
17. See Supporting Information.
18. Ooya, T.; Yui, N. Macromol. Chem. Phys. 1998, 199, 2311-2320.
19. (a) Ooya, T.; Eguchi, M.; Yui, N. J. Am. Chem. Soc. 2003, 125, 13016-13017.
20. (b) Ooya, T.; Utsunomiya, T.; Eguchi, M.; Yui, N. Bioconjugate Chem. 2005, 16, 62-69.
21. (tot) × 100. See: Akita, H.; Ito, R.; Khalil, I. A.; Futaki, S.; Harashima, H. Mol. Ther. 2004, 9, 443-451.